Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | 23 | 0 | 3 | 0 | €69.00 | €79.43 | 15.115% |
| Biogen Inc. | 44 | 1 | 3 | 0 | €195.30 | €294.45 | 50.767% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.30 | €421.61 | 16.049% |
| BioMarin Pharmaceutical Inc. | 21 | 0 | 3 | 0 | €75.64 | €102.62 | 35.668% |
| Icon plc | 18 | 0 | 3 | 0 | €288.20 | €318.99 | 10.685% |
| Neurocrine Bioscience | 23 | 0 | 2 | 0 | €127.05 | €137.63 | 8.331% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 2 | 0 | €41.40 | €82.93 | 100.317% |
| Zoetis Inc. A | 20 | 1 | 1 | 0 | €148.06 | €201.64 | 36.185% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €29.60 | €38.99 | 31.718% |
| Heron Therapeutics Inc. | 9 | 1 | 1 | 0 | €2.29 | €4.57 | 99.381% |
| Abbott Laboratories | 16 | 0 | 1 | 0 | €100.48 | €116.81 | 16.250% |
| XOMA Corp. | 4 | 0 | 1 | 0 | €22.80 | €68.78 | 201.664% |
| Esperion Therapeutis.Inc. | 12 | 0 | 1 | 0 | €1.77 | €8.39 | 373.395% |
| X4 Pharmaceuticals, Inc. | 4 | 0 | 1 | 0 | €1.09 | €2.76 | 153.003% |
| Rhythm Pharmaceuticals | 14 | 0 | 1 | 0 | €36.60 | €46.08 | 25.908% |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | €39.00 | - | - |
| Acorda Therapeutics Cdt | 15 | 0 | 1 | 0 | €0.47 | - | - |
| Krystal Biotech | 16 | 0 | 1 | 0 | €145.15 | €173.22 | 19.338% |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 1 | 0 | €825.20 | €957.22 | 15.999% |
| Corcept Therapeutics Inc. | 9 | 0 | 1 | 0 | €21.32 | €33.55 | 57.348% |
| Insmed Inc. | 13 | 1 | 1 | 0 | €23.20 | €44.01 | 89.684% |
| MacroGenics Inc. | 11 | 0 | 1 | 0 | €13.58 | €20.00 | 47.275% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €122.60 | €124.93 | 1.900% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| United Therapeutics | 15 | 0 | 0 | 0 | €220.00 | €289.92 | 31.782% |